Neonatal group B streptococcal cellulitis-adenitis.
A 38-day-old prematurely born infant developed rapidly progressive facial cellulitis in association with ipsilateral submandibular lymphadenopathy and pulmonary consolidation. Group B streptococci (GBS) were isolated from blood, endotracheal, and lesion cultures. Prompt recognition of GBS cellulitis-adenitis and institution of parenteral, synergistic antibiotic therapy are important.
Barton
L L
LL
Department of Pediatrics, University of Arizona Health Sciences Center, Tucson 85724.
Ramsey
R A
RA
Raval
D S
DS
D000667:Ampicillin / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000382:microbiology; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy / Q000382:microbiology*; D008199:Lymphadenitis / Q000188:drug therapy / Q000382:microbiology*; D013290:Streptococcal Infections / Q000188:drug therapy; D013292:Streptococcus agalactiae
D005839:Gentamicins; D000667:Ampicillin